Evidence map›Paper›PMID 34646141›Full record

ArticleFrontiers in pharmacology2021

Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States.

Jigang Chen, Xin Tong, Mingyang Han, Songfeng Zhao, Linjin Ji, Yongkai Qin, Zilong He, Yuesong Pan, Chunhui Wang, Aihua Liu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Jigang ChenBeijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Xin TongBeijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Mingyang HanDepartment of Neurosurgery, The Third Xiangya Hospital, Central South University, Changsha, China.
Songfeng ZhaoDepartment of Neurosurgery, The Third Xiangya Hospital, Central South University, Changsha, China.
Linjin JiDepartment of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yongkai QinDepartment of Neurosurgery, The Third Xiangya Hospital, Central South University, Changsha, China.
Zilong HeDepartment of Neurosurgery, The Third Xiangya Hospital, Central South University, Changsha, China.
Yuesong PanDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Chunhui WangDepartment of Neurosurgery, The 905th Hospital, Naval Medical University, Shanghai, China.
Aihua LiuBeijing Neurosurgical Institute, Capital Medical University, Beijing, China.
Central South University · CNBeijing Institute of Neurosurgery · CNBeijing Tian Tan Hospital · CNFirst Affiliated Hospital of Nanchang University · CNThird Xiangya Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cost-effectiveglioblastoma multiformeradiotherapytemozolomidetreatment

Identifiers

PMID34646141
PMCPMC8502816
OpenAlexW3204466802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.